Xencor (XNCR) Stock: Buy, Sell, or Hold?
XNCR - Xencor, Inc.
$24.00
0.61 (2.61%)
▲
5d:
-2.04%
30d:
+1.22%
90d:
+37.38%
WAIT
LOW Confidence
Analysis Updated: Oct 15, 2026 12:00 AM ET
Earnings: Nov 04, 2026
18d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Oct 13, 2026 at $24.77 · last confirmed Oct 15, 2026
Strength: 6.3/10
Get Alerted When XNCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: XNCR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: XNCR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: XNCR is currently trading at $24.00, which is considered oversold relative to its 30-day fair value range of $24.00 to $25.34.
Technical Outlook: Technically, XNCR is in a strong uptrend. Immediate support is located at $22.56, while resistance sits at $26.03.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $31.42 (+30.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XNCR is in a strong uptrend. Immediate support is located at $22.56, while resistance sits at $26.03.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $31.42 (+30.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$24.00 -
$25.34
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.9% below Wall St target ($31.42)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$24.00 -
$25.34
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$22.56
Resistance Level
$26.03
Current Trend
Strong Uptrend
Technical data as of
Oct 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.75
Wall Street Target
$31.42
(+30.9%)
Revenue Growth (YoY)
17.5%
Profit Margin
-155.6%
Share & Embed Analysis
Last updated: October 16, 2026 1:23 AM ET
Data refreshes hourly during market hours. Next update: 2:23 AM
Data refreshes hourly during market hours. Next update: 2:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XNCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$259 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
20 analysts |
$95 | 50 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$73 | 51 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$36 | 53 HOLD |
|
MAZE
Maze Therapeutics, Inc. … |
STRONG BUY
13 analysts |
$62 | 48 HOLD |
